A multidisciplinary study published in Nature has elucidated the structure of the machinery responsible for writing much of our "dark genome"—the 98% of our DNA that has largely unknown biological function. These results may spur entirely novel treatments for autoimmune diseases, cancer and neurodegeneration.
